PATRICIA KARWAN: Open Payments
NPI 1700883568 · WAKEFIELD, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 27 payments from 17 companies in 2025. Trend: 2023 $228 · 2024 $83 · 2025 $710
Food & beverage: $611Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $173 |
| Incyte Corporation | 3 | $64 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| SOBI, INC | 1 | $36 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| SpringWorks Therapeutics, Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $33 |
| Agios Pharmaceuticals, Inc. | 2 | $32 |
Products named: DARZALEX, JAKAFI, ZYNLONTA, FRUZAQLA, TECVAYLI, Vonjo, RYBREVANT, OGSIVEO.
Industry payments across RI — which companies pay providers there.
